Crossmark

Nonclinical and clinical pharmacological characterization of the potent and selective cathepsin K inhibitor MIV-711

Crossref DOI link: https://doi.org/10.1186/s12967-018-1497-4

Published Online: 2018-05-09

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Lindström, Erik

Rizoska, Biljana https://orcid.org/0000-0002-9946-7174
Henderson, Ian

Terelius, Ylva

Jerling, Markus

Edenius, Charlotte

Grabowska, Urszula
License Information

Text and Data Mining valid from 2018-05-09
More Information

Article History

Received: 12 October 2017

Accepted: 30 April 2018

First Online: 9 May 2018